Stoke Therapeutics, Inc. (STOK)

34.32 +1.13 (+3.40%) USD  |  NASDAQ  |  Mar 16, 15:25
More

Stoke Therapeutics EPS Diluted (Quarterly YoY Growth)

EPS Diluted (Quarterly YoY Growth) Chart

View EPS Diluted (Quarterly YoY Growth) for STOK.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (Quarterly YoY Growth) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS Diluted (Quarterly YoY Growth) Range, Past 5 Years

View EPS Diluted (Quarterly YoY Growth) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (Quarterly YoY Growth) Benchmarks

View EPS Diluted (Quarterly YoY Growth) Benchmarks
Start Trial
Biogen, Inc. Upgrade
Krystal Biotech, Inc. Upgrade
Scholar Rock Holding Corp. Upgrade
Vertex Pharmaceuticals, Inc. Upgrade
Zymeworks, Inc. Upgrade